86 related articles for article (PubMed ID: 8770086)
1. Peripheral artery structure and endothelial function in heart failure: effect of ACE inhibition.
Mulder P; Elfertak L; Richard V; Compagnon P; Devaux B; Henry JP; Scalbert E; Desché P; Macé B; ThuilleZ C
Am J Physiol; 1996 Aug; 271(2 Pt 2):H469-77. PubMed ID: 8770086
[TBL] [Abstract][Full Text] [Related]
2. Response of large and small vessels to alpha and beta adrenoceptor stimulation in heart failure: effect of angiotensin converting enzyme inhibition.
Mulder P; Compagnon P; Devaux B; Richard V; Henry JP; Elfertak L; Wimart MC; Thibout E; Comoy E; Macé B; Thuillez C
Fundam Clin Pharmacol; 1997; 11(3):221-30. PubMed ID: 9243253
[TBL] [Abstract][Full Text] [Related]
3. Vascular and myocardial protective effects of converting enzyme inhibition in experimental heart failure.
Mulder P; Devaux B; el Fertak L; Compagnon P; Richard V; Henry JP; Scalbert E; Desché P; Macé B; Thuillez C
Am J Cardiol; 1995 Nov; 76(15):28E-33E. PubMed ID: 7484884
[TBL] [Abstract][Full Text] [Related]
4. Improvement of endothelial function by chronic angiotensin-converting enzyme inhibition in heart failure : role of nitric oxide, prostanoids, oxidant stress, and bradykinin.
Varin R; Mulder P; Tamion F; Richard V; Henry JP; Lallemand F; Lerebours G; Thuillez C
Circulation; 2000 Jul; 102(3):351-6. PubMed ID: 10899101
[TBL] [Abstract][Full Text] [Related]
5. Prevention of endothelial dysfunction in small and large arteries in a model of chronic heart failure. Effect of angiotensin converting enzyme inhibition.
Thuillez C; Mulder P; Elfertak L; Blaysat G; Compagnon P; Henry JP; Richard V; Scalbert E; Desche P
Am J Hypertens; 1995 May; 8(5 Pt 2):7S-12S. PubMed ID: 7646844
[TBL] [Abstract][Full Text] [Related]
6. The effect of chronic treatment with trandolapril on cyclic AMP-and cyclic GMP-dependent relaxations in aortic segments of rats with chronic heart failure.
Toyoshima H; Nasa Y; Kohsaka Y; Isayama Y; Yamaguchi F; Sanbe A; Takeo S
Br J Pharmacol; 1998 Jan; 123(2):344-52. PubMed ID: 9489624
[TBL] [Abstract][Full Text] [Related]
7. Early versus delayed angiotensin-converting enzyme inhibition in experimental chronic heart failure. Effects on survival, hemodynamics, and cardiovascular remodeling.
Mulder P; Devaux B; Richard V; Henry JP; Wimart MC; Thibout E; Macé B; Thuillez C
Circulation; 1997 Mar; 95(5):1314-9. PubMed ID: 9054865
[TBL] [Abstract][Full Text] [Related]
8. Perindopril treatment prevents the loss of endothelial nitric oxide function and development of neo-intima in rabbits.
Hickey H; Makdissi M; Hyland R; Wilks D; Dusting GJ
J Mol Cell Cardiol; 1996 Sep; 28(9):1985-94. PubMed ID: 8899557
[TBL] [Abstract][Full Text] [Related]
9. Acute and chronic in vivo inhibition of angiotensin-converting enzyme by perindopril in the endothelium and adventitia of large arteries and organs of the rabbit.
Zhuo J; Casley D; Murone C; Mendelsohn FA
J Cardiovasc Pharmacol; 1997 Mar; 29(3):297-310. PubMed ID: 9125666
[TBL] [Abstract][Full Text] [Related]
10. Addition of the selective aldosterone receptor antagonist eplerenone to ACE inhibition in heart failure: effect on endothelial dysfunction.
Schäfer A; Fraccarollo D; Hildemann SK; Tas P; Ertl G; Bauersachs J
Cardiovasc Res; 2003 Jun; 58(3):655-62. PubMed ID: 12798439
[TBL] [Abstract][Full Text] [Related]
11. Perindopril chronically inhibits angiotensin-converting enzyme in both the endothelium and adventitia of the internal mammary artery in patients with ischemic heart disease.
Zhuo JL; Froomes P; Casley D; Liu JJ; Murone C; Chai SY; Buxton B; Mendelsohn FA
Circulation; 1997 Jul; 96(1):174-82. PubMed ID: 9236432
[TBL] [Abstract][Full Text] [Related]
12. Endothelial dysfunction in congestive heart failure: ACE inhibition vs. angiotensin II antagonism.
Schäfer A; Fraccarollo D; Tas P; Schmidt I; Ertl G; Bauersachs J
Eur J Heart Fail; 2004 Mar; 6(2):151-9. PubMed ID: 14984722
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-(1-7) Selectively Induces Relaxation and Modulates Endothelium-Dependent Dilation in Mesenteric Arteries of Salt-Fed Rats.
Raffai G; Lombard JH
J Vasc Res; 2016; 53(1-2):105-118. PubMed ID: 27676088
[TBL] [Abstract][Full Text] [Related]
14. Endothelium-dependent and -independent vasoreactivity of rat basilar artery in chronic heart failure.
Widder J; Bauersachs J; Fraccarollo D; Ertl G; Schilling L
J Cardiovasc Pharmacol; 2000 Apr; 35(4):515-22. PubMed ID: 10774779
[TBL] [Abstract][Full Text] [Related]
15. Effects of long-term treatment with trandolapril on sarcoplasmic reticulum function of cardiac muscle in rats with chronic heart failure following myocardial infarction.
Yamaguchi F; Sanbe A; Takeo S
Br J Pharmacol; 1998 Jan; 123(2):326-34. PubMed ID: 9489622
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial dysfunction and superoxide anion production in heart failure are p38 MAP kinase-dependent.
Widder J; Behr T; Fraccarollo D; Hu K; Galuppo P; Tas P; Angermann CE; Ertl G; Bauersachs J
Cardiovasc Res; 2004 Jul; 63(1):161-7. PubMed ID: 15194473
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease.
Petrie MC; Padmanabhan N; McDonald JE; Hillier C; Connell JM; McMurray JJ
J Am Coll Cardiol; 2001 Mar; 37(4):1056-61. PubMed ID: 11263608
[TBL] [Abstract][Full Text] [Related]
18. Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction: role of vascular superoxide anion formation and endothelial nitric oxide synthase expression.
Bauersachs J; Heck M; Fraccarollo D; Hildemann SK; Ertl G; Wehling M; Christ M
J Am Coll Cardiol; 2002 Jan; 39(2):351-8. PubMed ID: 11788231
[TBL] [Abstract][Full Text] [Related]
19. ACE inhibitors in HF restore canine pulmonary endothelial function and ANG II vasoconstriction.
Straeter-Knowlen IM; Dell'italia LJ; Dai J; Hankes GH; Dillon AR; Cartee RE; Pohost GM; Ku DD
Am J Physiol; 1999 Nov; 277(5):H1924-30. PubMed ID: 10564148
[TBL] [Abstract][Full Text] [Related]
20. Improvement of peripheral endothelial dysfunction by protein tyrosine phosphatase inhibitors in heart failure.
Vercauteren M; Remy E; Devaux C; Dautreaux B; Henry JP; Bauer F; Mulder P; Hooft van Huijsduijnen R; Bombrun A; Thuillez C; Richard V
Circulation; 2006 Dec; 114(23):2498-507. PubMed ID: 17101854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
